Rainer Rupprecht Selected Research

Rainer Rupprecht Research Topics

Disease

16	Panic Disorder (Panic Attack) 10/2014 - 01/2002
15	Anxiety Disorders (Anxiety Disorder) 03/2022 - 01/2002
13	Major Depressive Disorder (Major Depressive Disorders) 03/2022 - 06/2005
12	Tinnitus 01/2019 - 01/2012
10	Mood Disorders (Mood Disorder) 01/2017 - 03/2002
9	Neuroinflammatory Diseases 06/2022 - 01/2014
9	Sleep Deprivation 03/2016 - 05/2002
7	Neoplasms (Cancer) 12/2021 - 12/2005
7	Schizophrenia (Dementia Praecox) 05/2019 - 08/2004
6	Mental Disorders (Mental Disorder) 03/2022 - 01/2010
6	Depressive Disorder (Melancholia) 05/2019 - 04/2004
5	Bipolar Disorder (Manic Depressive Psychosis) 05/2019 - 07/2003
4	Glioma (Gliomas) 12/2021 - 01/2012
4	Inflammation (Inflammations) 01/2020 - 01/2014
3	Gliosis 02/2019 - 12/2010
2	Postpartum Depression (Post-Natal Depression) 03/2022 - 01/2022
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2019
2	Disease Progression 01/2021 - 03/2003
2	Infections 05/2019 - 01/2017
2	Multiple Sclerosis 10/2017 - 03/2010
2	Sleepiness 01/2017 - 03/2016
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2012 - 07/2009
2	Substance-Related Disorders (Drug Abuse) 01/2010 - 01/2008
2	Treatment-Resistant Depressive Disorder 01/2007 - 01/2006
1	Progressive Multifocal Leukoencephalopathy 06/2022
1	Acute Pain 05/2022
1	Cognitive Dysfunction 01/2022
1	Corticobasal Degeneration 01/2021
1	Necrosis 01/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021
1	Tauopathies 01/2021
1	Ischemia 02/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2018
1	Glioblastoma (Glioblastoma Multiforme) 07/2018
1	Relapsing-Remitting Multiple Sclerosis 10/2017
1	Fatigue 01/2017
1	Pain (Aches) 01/2017
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2016
1	Neuralgia (Stump Neuralgia) 01/2016

Drug/Important Bio-Agent (IBA)

18	NeurosteroidsIBA 03/2022 - 01/2002
16	Antidepressive Agents (Antidepressants)IBA 01/2017 - 03/2003
15	Proteins (Proteins, Gene)FDA Link 03/2022 - 07/2003
10	LigandsIBA 03/2022 - 07/2009
8	Pharmaceutical PreparationsIBA 06/2014 - 05/2002
7	gamma-Aminobutyric Acid (GABA)IBA 03/2022 - 01/2002
7	Anti-Anxiety Agents (Anxiolytics)IBA 01/2012 - 01/2003
7	TetragastrinIBA 01/2011 - 02/2003
6	GABA-A Receptors (GABA(A) Receptor)IBA 11/2012 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2010
5	Antipsychotic Agents (Antipsychotics)IBA 06/2014 - 11/2005
4	Amino Acids FDA Link 06/2022 - 07/2003
4	BenzodiazepinesIBA 01/2022 - 05/2005
4	Biological ProductsIBA 12/2018 - 01/2006
3	Pregnanolone (Allopregnanolone)IBA 03/2022 - 02/2014
3	CytokinesIBA 01/2021 - 05/2019
3	Quetiapine Fumarate (Seroquel)FDA Link 06/2014 - 01/2012
3	Mirtazapine (Rexer)FDA LinkGeneric 01/2009 - 03/2003
3	Sodium Lactate FDA LinkGeneric 01/2006 - 02/2003
2	brexanoloneIBA 03/2022 - 01/2022
2	zuranoloneIBA 03/2022 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 05/2019
2	ChemokinesIBA 05/2019 - 01/2017
2	Retinaldehyde (Retinal)IBA 02/2019 - 01/2014
2	N- benzyl- N- ethyl- 2- (7,8- dihydro- 7- methyl- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 02/2019 - 07/2009
2	Hypnotics and Sedatives (Sedatives)IBA 01/2019 - 01/2012
2	Butyric Acid (Butanoic Acid)IBA 11/2009 - 04/2004
2	Serotonin (5 Hydroxytryptamine)IBA 01/2009 - 11/2005
2	GTP-Binding Proteins (G-Protein)IBA 07/2002 - 03/2002
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2022
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	Opioid Analgesics (Opioids)IBA 05/2022
1	Immunologic Factors (Immunomodulators)IBA 03/2022
1	Diazepam (Valium)FDA LinkGeneric 01/2022
1	InterleukinsIBA 01/2021
1	Interleukin-7 (Interleukin 7)IBA 01/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	Interleukin-16 (Interleukin 16)IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	CC ChemokinesIBA 01/2020
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2019
1	C-Reactive ProteinIBA 05/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	tacrolimus binding protein 5IBA 03/2017
1	Hormones (Hormone)IBA 03/2017
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 03/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2017
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	Wakefulness-Promoting AgentsIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 03/2016
1	Desipramine (Pertofrane)FDA LinkGeneric 01/2016

Therapy/Procedure

14	Transcranial Magnetic Stimulation 01/2018 - 05/2002
7	Therapeutics 05/2021 - 01/2007
5	Drug Therapy (Chemotherapy) 01/2017 - 01/2006
2	Transcranial Direct Current Stimulation 01/2019 - 12/2017
2	Combined Modality Therapy 07/2018 - 01/2018